{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:58:41Z","timestamp":1782845921864,"version":"3.54.5"},"reference-count":41,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Mhealth Uhealth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The management of chronic obstructive pulmonary disease (COPD) places a significant burden on health care systems worldwide. Home noninvasive positive pressure ventilation (NPPV) is an established treatment option associated with significant benefits for patients with COPD and hypercapnic chronic respiratory failure. Internet of Things (IoT)\u2013based management may improve communication between patients and physicians and strengthen the integration and comprehensiveness of home NPPV telemonitoring. However, the economic value of such systems remains insufficiently understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to assess the cost-effectiveness of IoT-based management versus standard management of home NPPV in patients with COPD and hypercapnic chronic respiratory failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A Markov decision analytic model was developed to simulate real-world COPD progression and predict health outcomes and costs associated with IoT-based and standard management of home NPPV. COPD progression consisted of 4 health states: stable period, nonserious exacerbation period, serious exacerbation period, and death. Efficacy and cost inputs were primarily sourced from a published multicenter, prospective, randomized controlled trial and supplemented by official Chinese databases where necessary. Quality-adjusted life years (QALYs) were used as effect indicators for this model, which were derived from COPD Assessment Test scores. The discounted lifetime cost per QALY gained was calculated from the Chinese health care payer perspective, and sensitivity analyses were conducted to test the robustness of model results across different assumptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with standard NPPV, IoT-based NPPV increased costs by \u00a53607.26 and improved QALYs by 0.24 per person across the lifetime horizon, resulting in an incremental cost-effectiveness ratio of \u00a515,030.25 per QALY, with a 93.6% probability of being cost-effective at the given willingness-to-pay threshold (currency conversion to US dollars was based on the average exchange rate in 2019 [US $1=\u00a56.9]). Base case results were also robust to multiple one-way sensitivity analyses, with the main drivers being hospitalization costs for the standard and IoT-based NPPV groups during the serious exacerbation period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IoT-based NPPV was cost-effective compared with standard NPPV for patients with COPD and hypercapnic chronic respiratory failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/71340","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:40:07Z","timestamp":1776732007000},"page":"e71340-e71340","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness of Internet of Things\u2013Based Management of Home Noninvasive Positive Pressure Ventilation in Patients With Chronic Obstructive Pulmonary Disease and Hypercapnic Chronic Respiratory Failure: Trial-Based Economic Evaluation"],"prefix":"10.2196","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-9528","authenticated-orcid":false,"given":"Ruihua","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7069-1579","authenticated-orcid":false,"given":"Jiu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7464-6620","authenticated-orcid":false,"given":"Yueying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1465-7752","authenticated-orcid":false,"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3449-0927","authenticated-orcid":false,"given":"Yinghao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3028-891X","authenticated-orcid":false,"given":"Weipeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7616-1763","authenticated-orcid":false,"given":"Chenjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3373-6631","authenticated-orcid":false,"given":"Yuanlin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-3973","authenticated-orcid":false,"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"R1","unstructured":"Healthy China initiative (2019-2030) [Article in Chinese]. National Health Commission of the People\u2019s Republic of China. 2019. URL: https:\/\/www.nhc.gov.cn\/guihuaxxs\/c100133\/201907\/2a6ed52f1c264203b5351bdbbadd2da8.shtml [Accessed 25-04-2024]"},{"issue":"10258","key":"R2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","journal-title":"Lancet"},{"issue":"1","key":"R3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/CM9.0000000000003898","article-title":"Non-communicable disease burden in China, 1990\u20132023: evidence from the Global Burden of Disease study 2023","volume":"139","author":"Zhang","journal-title":"Chin Med J"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S161555","article-title":"Disease burden of COPD in China: a systematic review","volume":"13","author":"Zhu","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"4","key":"R5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152618","article-title":"Continuing to Confront COPD International Patient Survey: economic impact of COPD in 12 countries","volume":"11","author":"Foo","journal-title":"PLoS One"},{"issue":"8","key":"R6","doi-asserted-by":"publisher","first-page":"e1183","DOI":"10.1016\/S2214-109X(23)00217-6","article-title":"The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study","volume":"11","author":"Chen","journal-title":"Lancet Glob Health"},{"issue":"5","key":"R7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jama.2019.22343","article-title":"Association of home noninvasive positive pressure ventilation with clinical outcomes in chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"323","author":"Wilson","journal-title":"JAMA"},{"key":"R8","unstructured":"Global strategy for prevention, diagnosis and management of COPD: 2023 report. Global Initiative for Chronic Obstructive Lung Disease. URL: https:\/\/goldcopd.org\/2023-gold-report-2\/ [Accessed 25-05-2025]"},{"issue":"3","key":"R9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01003-2019","article-title":"European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD","volume":"54","author":"Ergan","journal-title":"Eur Respir J"},{"issue":"4","key":"R10","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1164\/rccm.202006-2382ST","article-title":"Long-term noninvasive ventilation in chronic stable hypercapnic chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline","volume":"202","author":"Macrea","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"R11","doi-asserted-by":"publisher","DOI":"10.1007\/s13755-018-0049-x","article-title":"A study on medical internet of things and big data in personalized healthcare system","volume":"6","author":"Jagadeeswari","journal-title":"Health Inf Sci Syst"},{"issue":"7","key":"R12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/crj.13352","article-title":"Titration and follow-up for home noninvasive positive pressure ventilation in chronic obstructive pulmonary disease: the potential role of tele-monitoring and the Internet of things","volume":"15","author":"Jiang","journal-title":"Clin Respir J"},{"issue":"13","key":"R13","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18136757","article-title":"A systematic review and meta-analysis of telemonitoring interventions on severe COPD exacerbations","volume":"18","author":"Jang","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"R14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/15412555.2010.481697","article-title":"The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review","volume":"7","author":"Toy","journal-title":"COPD"},{"issue":"3","key":"R15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1258\/jtt.2009.090812","article-title":"Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"16","author":"Polisena","journal-title":"J Telemed Telecare"},{"key":"R16","unstructured":"Liddell A Adshead S Burgess E . Technology in the NHS: transforming the patient\u2019s experience of care. The King\u2019s Fund. 2008. URL: https:\/\/assets.kingsfund.org.uk\/f\/256914\/x\/0fffdec1e2\/tehcnology_in_the_nhs_october_2008.pdf [Accessed 25-04-2024]"},{"key":"R17","unstructured":"Stroetmann KA Kubitschke L Robinson S Stroetmann V Cullen K McDaid D . How can telehealth help in the provision of integrated care. World Health Organization. 2010. URL: https:\/\/iris.who.int\/handle\/10665\/332044 [Accessed 25-04-2024]"},{"issue":"2","key":"R18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01128-2016","article-title":"Management of continuous positive airway pressure treatment compliance using telemonitoring in obstructive sleep apnoea","volume":"49","author":"Turino","journal-title":"Eur Respir J"},{"issue":"3","key":"R19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/thoraxjnl-2019-213303","article-title":"Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial","volume":"75","author":"Duiverman","journal-title":"Thorax"},{"issue":"11","key":"R20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1136\/thoraxjnl-2015-207032","article-title":"A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial","volume":"70","author":"Isetta","journal-title":"Thorax"},{"issue":"9","key":"R21","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.rmed.2014.07.008","article-title":"Initiation of home mechanical ventilation at home: a randomised controlled trial of efficacy, feasibility and costs","volume":"108","author":"Hazenberg","journal-title":"Respir Med"},{"issue":"6","key":"R22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3109\/17482968.2012.703675","article-title":"Economic cost of home-telemonitoring care for BiPAP-assisted ALS individuals","volume":"13","author":"Lopes de Almeida","journal-title":"Amyotroph Lateral Scler"},{"issue":"2","key":"R23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1183\/09031936.00005608","article-title":"Tele-assistance in chronic respiratory failure patients: a randomised clinical trial","volume":"33","author":"Vitacca","journal-title":"Eur Respir J"},{"issue":"6","key":"R24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/1357633X14544421","article-title":"Cost-utility analysis of a telehealth programme for patients with severe chronic obstructive pulmonary disease treated with long-term oxygen therapy","volume":"20","author":"J\u00f3dar-S\u00e1nchez","journal-title":"J Telemed Telecare"},{"issue":"2","key":"R25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/1357633X14566574","article-title":"Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial","volume":"21","author":"Stoddart","journal-title":"J Telemed Telecare"},{"issue":"mar20 4","key":"R26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1035","article-title":"Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial","volume":"346","author":"Henderson","journal-title":"BMJ"},{"issue":"3","key":"R27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/13993003.01721-2015","article-title":"Tele-monitoring of ventilator-dependent patients: a European Respiratory Society statement","volume":"48","author":"Ambrosino","journal-title":"Eur Respir J"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102518","article-title":"Internet of things-based management versus standard management of home noninvasive ventilation in COPD patients with hypercapnic chronic respiratory failure: a multicentre randomized controlled non-inferiority trial","volume":"70","author":"Jiang","journal-title":"eClinicalMedicine"},{"issue":"5","key":"R29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD Science Committee report 2019","volume":"53","author":"Singh","journal-title":"Eur Respir J"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.713258","article-title":"Cost-effectiveness analysis of triple combination preparations in the treatment of moderate-to-severe chronic obstructive pulmonary disease","volume":"9","author":"Zhou","journal-title":"Front Public Health"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Drummond ME Sculpher MJ Torrance GW et al. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford University Press; 2005. [doi: 10.1093\/oso\/9780198529446.001.0001] ISBN: 9781383024890","DOI":"10.1093\/oso\/9780198529446.001.0001"},{"issue":"1","key":"R32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24956-2","article-title":"Mapping algorithms for predicting EuroQol-5D-3L utilities from the assessment test of chronic obstructive pulmonary disease","volume":"12","author":"Yu","journal-title":"Sci Rep"},{"key":"R33","unstructured":"China Population and Employment Statistics Yearbook 2021. China Statistics Press; 2021. URL: https:\/\/www.chinayearbooks.com\/china-population-and-employment-statistics-yearbook-2021.html [Accessed 25-05-2025] ISBN: 9787503797637"},{"issue":"4","key":"R34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/00019053-199813040-00003","article-title":"An introduction to Markov modelling for economic evaluation","volume":"13","author":"Briggs","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"R35","doi-asserted-by":"publisher","DOI":"10.1186\/s13561-025-00650-7","article-title":"Impact of China Guidelines for Pharmacoeconomic Evaluations on study quality: a systematic review of economic evaluations in China","volume":"15","author":"Cao","journal-title":"Health Econ Rev"},{"issue":"4","key":"R36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/1357633X14533896","article-title":"A systematic review of the cost and cost-effectiveness of telehealth for patients suffering from chronic obstructive pulmonary disease","volume":"20","author":"Udsen","journal-title":"J Telemed Telecare"},{"issue":"9","key":"R37","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1089\/tmj.2011.0250","article-title":"Cost-utility analysis of a telerehabilitation program: a case study of COPD patients","volume":"18","author":"Haesum","journal-title":"Telemed J E Health"},{"issue":"3","key":"R38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4258\/hir.2016.22.3.156","article-title":"Medical internet of things and big data in healthcare","volume":"22","author":"Dimitrov","journal-title":"Healthc Inform Res"},{"issue":"10227","key":"R39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30424-4","article-title":"Telemedicine 2020 and the next decade","volume":"395","author":"Dorsey","journal-title":"Lancet"},{"issue":"10277","key":"R40","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S0140-6736(21)00458-X","article-title":"Improving lung health in low-income and middle-income countries: from challenges to solutions","volume":"397","author":"Meghji","journal-title":"Lancet"},{"issue":"2","key":"R41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001382","article-title":"Scaling up mHealth: where is the evidence?","volume":"10","author":"Tomlinson","journal-title":"PLoS Med"}],"container-title":["JMIR mHealth and uHealth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/mhealth.jmir.org\/2026\/1\/e71340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:00:37Z","timestamp":1782842437000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhealth.jmir.org\/2026\/1\/e71340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":41,"URL":"https:\/\/doi.org\/10.2196\/71340","relation":{},"ISSN":["2291-5222"],"issn-type":[{"value":"2291-5222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"article-number":"v14i10258e71340"}}